WeVote

Bill

Bill

S 1359

Requires health insurance companies to cover lead screenings for children 16 years of age or younger.

2026-2027 Regular Session

New Jersey bill requires health insurers to cover lead screenings for children under 17 with no out-of-pocket costs to detect harmful exposure early.

Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
0
WeVote Research Nonpartisan
Bill Summary · S 1359

Legislative bill overview

S 1359 mandates that all health insurance plans in New Jersey cover lead screening tests for children aged 16 and younger without cost-sharing (copays, coinsurance, or deductibles). The bill ensures that these screenings are accessible preventive care, treating lead exposure detection as a covered benefit similar to other pediatric preventive services.

Why is this important

Lead exposure in children can cause permanent neurological damage, developmental delays, reduced IQ, and behavioral problems, even at low levels. Early detection through screening allows for intervention and remediation before significant harm occurs. Making screenings universally covered removes financial barriers that might prevent at-risk children from being tested and identified.

Potential points of contention

  • Cost allocation: Insurance companies may argue the mandate increases premiums for all policyholders, and debate whether the state or health plans should bear screening costs
  • Scope and frequency: Unclear whether the bill specifies how many screenings per child per year are covered, or if it covers only initial screening versus ongoing monitoring
  • Coverage gaps: Children on Medicaid or uninsured children may still lack access, meaning the mandate doesn't address the most vulnerable populations who face highest lead exposure risk

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.